Skip to main content
VRTX logo

Vertex Pharmaceuticals Incorporated

VRTXNASDAQHealthcareBiotechnology

$535.17Today:- (-)1Y +26.63%

As of Oct 22, 2026 close

Market cap
$136.58B
P/E (TTM)
31.00
Forward P/E
25.71
Dividend yield
-
52-week range
$403.16$560.25
Volume (live)
-
Avg. volume (3M)
1.18M

Vertex Pharmaceuticals Incorporated (VRTX) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Vertex Pharmaceuticals Incorporated stock.

Analyst Consensus Rating

Investment consensus from 27 professional research analysts

Consensus Rating

Buy
Based on 27 unique analysts
(31 total ratings in last 90 days)
Very High Confidence21.0:1 Buy/Sell

Average Price Target

$589.45
+10.14% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest VRTX Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Tazeen Ahmad
BofA Securities
BuyMaintains
$667.00
Mohit Bansal
Wells Fargo
BuyMaintains
$550.00
Geoff Meacham
Citi
BuyMaintains
$575.00 → $585.00
Evan Seigerman
BMO Capital
BuyMaintains
$600.00
Brian Abrahams
RBC Capital
BuyMaintains
$570.00 → $576.00
Terence Flynn
Morgan Stanley
BuyReiterates
$665.00
Zacks Equity Research
Zacks Equity Research
HoldInitiates Coverage
-
Tazeen Ahmad
BofA Securities
BuyMaintains
-
Edmund Ingham
Forbes
SellInitiates Coverage
-
Michael Yee
UBS
BuyMaintains
$585.00 → $615.00
Jeffrey Walch
Bernstein
BuyMaintains
$608.00
Kinjel Shah
Zacks Equity Research
HoldInitiates Coverage
-
Unknown Analyst
Jefferies
BuyMaintains
$633.00 → $640.00
Salveen Richter
Goldman Sachs
BuyMaintains
$653.00
Danielle Brill
Truist
BuyMaintains
-
Evan Seigerman
BMO Capital
BuyReiterates
$600.00
Louise Chen
Scotiabank
BuyMaintains
$558.00
Whitney Ijem
Canaccord Genuity
HoldMaintains
$442.00
Eliana Merle
Barclays
BuyMaintains
$617.00
Salveen Richter
Goldman Sachs
BuyMaintains
$653.00
Myles Minter
William Blair
BuyMaintains
-
Andrew Fein
HC Wainwright
BuyMaintains
$641.00
Paul Matteis
Stifel Nicolaus
HoldMaintains
-
Jessica Fye
JP Morgan
BuyInitiates
$515.00 → $560.00
Naz Rahman
Maxim
BuyReiterates
$575.00
Phil Nadeau
TD Cowen
BuyInitiates Coverage
$525.00 → $550.00
Carter Gould
Cantor Fitzgerald
BuyMaintains
$590.00 → $595.00
Cory Kasimov
Evercore ISI Group
BuyMaintains
$535.00
Joseph Stringer
Needham
HoldMaintains
-
Mohit Bansal
Wells Fargo
BuyInitiates Coverage
$540.00 → $550.00
Andy Chen
Wolfe Research
BuyMaintains
$557.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 15, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for VRTX?

The analyst consensus rating for VRTX is Buy, based on the latest ratings from 27 analysts over the last 90 days.

What is the average price target for VRTX?

The average 12-month price target for VRTX is $589.45, representing an upside of 10.1% from the Oct 22, 2026 close of $535.17.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.